myelodysplastic syndrome
Long-term erythropoietin therapy improves response in myelodysplastic syndrome.
Long-term <span class="gene" id="16076383-0-10-24">erythropoietin</span> therapy improves response in <span class="disease" id="16076383-0-54-78">myelodysplastic syndrome</span>.